ERBB2 and breast cancer: LINC02159, also known as LOC285629, was DE in thyroid cancer, HER2+HR− breast cancer, and metastatic melanoma, and it was identified as a part of lncRNA signatures in colorectal cancer as well as head and neck squamous cell carcinoma [35, 36, 37, 38, 39, 40].